Contracter une TE après une greffe de la moelle pour une LMC
Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia
KHOURY H.; ADKINS D. ; ZEHNBAUER B. ; GOODNOUGH L. ; BROWN R. ; SAFDAR S. ; DIPERSIO J. F. ;
Washington University School of Medicine, Division of Bone Marrow Transplantation and Stem Cell Biology, St Louis, MO, ETATS-UNIS
''Allogeneic transplant recipients are at high risk of developing secondary malignancies as a late complication of therapy. We report a case of essential thrombocythemia occurring 8 years following bone marrow transplantation (BMT) for chronic myelogenous leukemia.''
http://cat.inist.fr/?aModele=afficheN&cpsidt=2274297